Skip to main content

Bio-Rad Acquires SafePath Food Testing Assets

NEW YORK (GenomeWeb News) — Bio-Rad Laboratories said today that it has purchased some of the assets of SafePath Laboratories' food diagnostics business for an undisclosed sum.

With the purchase, Bio-Rad acquired SafePath’s test kits for the Trichinella, Toxoplasma, and Salmonella pathogens.

SafePath develops and sells diagnostic tests for food safety and animal health, including tests for detecting food-borne bacteria and allergens.

Filed under

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.